1. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial 
Dr Valerie J Page, MBBCh, Prof E Wesley Ely, MD, Prof Simon Gates, PhD, Xiao Bei Zhao, RN, Timothy Alce, PhD, Ayumi Shintani, PhD, Jim Jackson, PsyD, Prof Gavin D Perkins, MD, Prof Daniel F McAuley, MD 
The Lancet Respiratory Medicine 
Volume 1, Issue 7, Pages (September 2013)
DOI: /S (13)
Copyright © 2013 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profile
*20 patients had more than one reason for exclusion.
The Lancet Respiratory Medicine 2013 1, DOI: ( /S (13) )
Copyright © 2013 Elsevier Ltd Terms and Conditions

3. Figure 2
Proportion of study patients with resolution of delirium over time
The Lancet Respiratory Medicine 2013 1, DOI: ( /S (13) )
Copyright © 2013 Elsevier Ltd Terms and Conditions

4. Figure 3 Study patients with agitation in first 14 days
The Lancet Respiratory Medicine 2013 1, DOI: ( /S (13) )
Copyright © 2013 Elsevier Ltd Terms and Conditions